367 related articles for article (PubMed ID: 27819528)
1. Interferon-gamma (IFN-γ) is Elevated in Wound Exudate from Hidradenitis Suppurativa.
Banerjee A; McNish S; Shanmugam VK
Immunol Invest; 2017 Feb; 46(2):149-158. PubMed ID: 27819528
[TBL] [Abstract][Full Text] [Related]
2. Inherent differences in keratinocyte function in hidradenitis suppurativa: Evidence for the role of IL-22 in disease pathogenesis.
Jones D; Banerjee A; Berger PZ; Gross A; McNish S; Amdur R; Shanmugam VK
Immunol Invest; 2018 Jan; 47(1):57-70. PubMed ID: 28972431
[TBL] [Abstract][Full Text] [Related]
3. Pathogenetic Characteristics of Mesenchymal Stem Cells in Hidradenitis Suppurativa.
Campanati A; Orciani M; Sorgentoni G; Consales V; Offidani A; Di Primio R
JAMA Dermatol; 2018 Oct; 154(10):1184-1190. PubMed ID: 30140888
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β.
van der Zee HH; de Ruiter L; van den Broecke DG; Dik WA; Laman JD; Prens EP
Br J Dermatol; 2011 Jun; 164(6):1292-8. PubMed ID: 21332464
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology of hidradenitis suppurativa: An update.
Prens E; Deckers I
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S8-11. PubMed ID: 26470623
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of steroid hormone receptors in hidradenitis suppurativa.
Buimer MG; Wobbes T; Klinkenbijl JH; Reijnen MM; Blokx WA
Am J Dermatopathol; 2015 Feb; 37(2):129-32. PubMed ID: 25229569
[TBL] [Abstract][Full Text] [Related]
7. Tumour necrosis factor-alpha and matrix metalloproteinase-2 are expressed strongly in hidradenitis suppurativa.
Mozeika E; Pilmane M; Nürnberg BM; Jemec GB
Acta Derm Venereol; 2013 May; 93(3):301-4. PubMed ID: 23096596
[TBL] [Abstract][Full Text] [Related]
8. Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa.
Del Duca E; Morelli P; Bennardo L; Di Raimondo C; Nisticò SP
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182701
[TBL] [Abstract][Full Text] [Related]
9. Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study.
van der Zee HH; Laman JD; de Ruiter L; Dik WA; Prens EP
Br J Dermatol; 2012 Feb; 166(2):298-305. PubMed ID: 22013960
[TBL] [Abstract][Full Text] [Related]
10. Hidradenitis Suppurativa Is Characterized by Dysregulation of the Th17:Treg Cell Axis, Which Is Corrected by Anti-TNF Therapy.
Moran B; Sweeney CM; Hughes R; Malara A; Kirthi S; Tobin AM; Kirby B; Fletcher JM
J Invest Dermatol; 2017 Nov; 137(11):2389-2395. PubMed ID: 28652108
[TBL] [Abstract][Full Text] [Related]
11. The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.
Shah A; Alhusayen R; Amini-Nik S
Inflamm Res; 2017 Nov; 66(11):931-945. PubMed ID: 28656364
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of antinuclear antibodies in hidradenitis suppurativa.
Mulani S; McNish S; Jones D; Shanmugam VK
Int J Rheum Dis; 2018 May; 21(5):1018-1022. PubMed ID: 29878616
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa.
Thomi R; Yerly D; Yawalkar N; Simon D; Schlapbach C; Hunger RE
Br J Dermatol; 2017 Nov; 177(5):1358-1366. PubMed ID: 28301691
[TBL] [Abstract][Full Text] [Related]
14. Inflammation induced changes in the expression levels of components of the microRNA maturation machinery Drosha, Dicer, Drosha co-factor DGRC8 and Exportin-5 in inflammatory lesions of hidradenitis suppurativa patients.
Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG
J Dermatol Sci; 2016 Jun; 82(3):166-74. PubMed ID: 26917346
[TBL] [Abstract][Full Text] [Related]
15. Hidradenitis suppurativa managed with adalimumab.
Yamauchi PS; Mau N
J Drugs Dermatol; 2009 Feb; 8(2):181-3. PubMed ID: 19213236
[TBL] [Abstract][Full Text] [Related]
16. Marjolin ulcer in hidradenitis suppurativa: case reports.
Grewal NS; Wan DC; Roostaeian J; Rubayi SR
Ann Plast Surg; 2010 Mar; 64(3):315-7. PubMed ID: 20179481
[TBL] [Abstract][Full Text] [Related]
17. What causes hidradenitis suppurativa?
Kurzen H; Kurokawa I; Jemec GB; Emtestam L; Sellheyer K; Giamarellos-Bourboulis EJ; Nagy I; Bechara FG; Sartorius K; Lapins J; Krahl D; Altmeyer P; Revuz J; Zouboulis CC
Exp Dermatol; 2008 May; 17(5):455-6; discussion 457-72. PubMed ID: 18400064
[TBL] [Abstract][Full Text] [Related]
18. Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa.
Emelianov VU; Bechara FG; Gläser R; Langan EA; Taungjaruwinai WM; Schröder JM; Meyer KC; Paus R
Br J Dermatol; 2012 May; 166(5):1023-34. PubMed ID: 22136668
[TBL] [Abstract][Full Text] [Related]
19. Hidradenitis Suppurativa: Absence of Hyperhidrosis but Presence of a Proinflammatory Signature in Patients' Sweat.
Frings VG; Roth N; Gläsel M; Bauer B; Goebeler M; Presser D; Kerstan A
Acta Derm Venereol; 2022 Oct; 102():adv00793. PubMed ID: 36172698
[TBL] [Abstract][Full Text] [Related]
20. [Ultrasound examination of hidradenitis suppurativa].
Martorell A; Segura Palacios JM
Actas Dermosifiliogr; 2015 Nov; 106 Suppl 1():49-59. PubMed ID: 26895939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
